Daniela Kohlbrecher-Kleine
Horsholm, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Preclinical evaluation of a CCL19 immune-potentiated DNA cancer vaccine.
Journal: Cancer immunology, immunotherapy : CII
Published: March 31, 2025
Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
Journal: Journal for immunotherapy of cancer
Published: May 01, 2024
Refined analytical pipeline for the pharmacodynamic assessment of T-cell responses to vaccine antigens.
Journal: Frontiers in immunology
Published: March 20, 2024
Corrigendum: Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.
Journal: Frontiers in immunology
Published: September 07, 2023
Discovery of NSD2-Degraders from Novel and Selective DEL Hits.
Journal: Chembiochem : a European journal of chemical biology
Published: July 17, 2023
Targeting neoantigens to APC-surface molecules improves the immunogenicity and anti-tumor efficacy of a DNA cancer vaccine.
Journal: Frontiers in immunology
Published: June 05, 2023
DNA based neoepitope vaccination induces tumor control in syngeneic mouse models.
Journal: NPJ vaccines
Published: September 23, 2022
Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors.
Journal: Cancer research
Published: January 23, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026